Faeth Therapeutics, Inc. FTH
Set alert
19.23 USD +0.54 +2.89%
At close · Nov 2
19.23 0.00 0.00%
After hours · Nov 2, 4:00 PM ET
18.36 Day range 20.01
7.45 52-week range 42.14
- YTD
- +80.22%
- 1 year
- +109.71%
- Open
- 18.69
- Prev close
- 18.69
- Mkt cap
- 496.91M
- Vol
- 212.61K
- Avg vol
- 374.70K
- EPS
- -60.96
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 18.36
- High
- 20.01
- Forward P/E
- -7.88
- Beta
- -0.28
- Short ratio
- 3.64
- Inst. own
- 78.84%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 13, 2026
- 50-d avg
- 30.99
- 200-d avg
- 22.28
- 1y target
- 54.64
6M chart
Events in this range
- May 15, 2026Earnings: -131.45; estimate -0.62; surprise -21101.61%
- Jul 31, 2026Rating: Raymond James · — → Outperform
- Aug 4, 2026Earnings: -2.84; estimate -2.64; surprise -7.58%
- Aug 4, 2026Rating: Jones Trading · — → Buy
- Aug 11, 2026Rating: HC Wainwright & Co. · Buy → Buy
- Aug 21, 2026Rating: Needham · — → Buy
- Sep 9, 2026Rating: TD Cowen · — → Buy
- Sep 14, 2026Rating: LUCID CAPITAL MARKETS · — → Buy
Signals (26)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 29, 2026 | 4 days ago |
| RSI: Oversold | Oct 23, 2026 | 1 week ago |
| RSI: Oversold | Oct 13, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 7, 2026 | 3 weeks ago |
| SMA: Bearish | Sep 23, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 15, 2026 | 1 month ago |
| RSI: Overbought | Sep 2, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 14, 2026 | 2 months ago |
| SMA: Bullish | Aug 10, 2026 | 2 months ago |
| SMA: Bearish | Aug 5, 2026 | 2 months ago |
| MACD: Sell Signal | Jul 17, 2026 | 3 months ago |
| RSI: Overbought | Jul 9, 2026 | 3 months ago |
| SMA: Bullish | Jul 7, 2026 | 3 months ago |
| SMA: Bearish | Jul 1, 2026 | 4 months ago |
| SMA: Bullish | Jun 30, 2026 | 4 months ago |
| SMA: Bearish | Jun 26, 2026 | 4 months ago |
| SMA: Bullish | Jun 23, 2026 | 4 months ago |
| SMA: Bullish | Jun 22, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 16, 2026 | 4 months ago |
| RSI: Oversold | Jun 9, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 8, 2026 | 4 months ago |
| MACD: Buy Signal | May 29, 2026 | 5 months ago |
| RSI: Oversold | May 18, 2026 | 5 months ago |
| RSI: Oversold | May 14, 2026 | 5 months ago |
| SMA: Bearish | May 11, 2026 | 5 months ago |
| RSI: Oversold | May 11, 2026 | 5 months ago |
Financial health
Altman Z-Score
11.91 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B-3 / 5 overall
- DCF 3
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 5
Valuation
P/E -0.6×
FY 2018 5y median -0.6× FY 2025
P/S 0.0×
FY 2018 5y median 0.0× FY 2025
P/B 0.7×
FY 2018 5y median 0.4× FY 2025
P/FCF -0.7×
FY 2018 5y median -0.7× FY 2025
EV/EBITDA -0.3×
FY 2018 5y median -0.4× FY 2025
EV/Sales 0.0×
FY 2018 5y median 0.0× FY 2025
FCF Yield -152.2%
FY 2018 5y median -152.2% FY 2025
Profitability
Gross Margin 0.0%
FY 2018 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2018 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2018 5y median 0.0% FY 2025
ROE -113.4%
FY 2018 5y median -52.5% FY 2025
ROIC -110.9%
FY 2018 5y median -52.1% FY 2025
ROA -92.1%
FY 2018 5y median -45.9% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2018 FY 2025
Operating Income 29.6%
FY 2018 FY 2025
EPS (diluted) 30.4%
FY 2018 FY 2025
Free Cash Flow 17.5%
FY 2018 FY 2025
Financial Health
Current Ratio 5.1×
FY 2018 5y median 11.9× FY 2025
Quick Ratio 5.1×
FY 2018 5y median 11.9× FY 2025
Debt / Equity 0.1×
FY 2018 5y median 0.1× FY 2025
Net Debt / EBITDA 0.3×
FY 2018 5y median 0.2× FY 2025
Interest Coverage -697×
FY 2018 5y median -257× FY 2025
Dividends
Dividend Yield 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31